Fitch Affirms AMRESCO Independent Funding, Inc. 1999-1
CHICAGO--(BUSINESS WIRE)-- Fitch Ratings affirms AMRESCO Independence Funding, Inc. 1999-1 loan-backed adjustable rate certificates as follows:
--Class A at 'Asf'; Outlook Stable;
--Class M at 'BBBsf'; Outlook Stable.
KEY RATING DRIVERS
The affirmation of AMRESCO Independence Funding, Inc. 1999-1 reflects the credit enhancement (CE) growth as both classes have greater than 50% CE. Both classes have Stable Outlooks as CE is expected to continue to provide adequate protection to the notes.
RATING METHODOLOGY
In reviewing the transactions, Fitch took into account analytical considerations outlined in Fitch's 'Global Structured Finance Rating Criteria', issued March 31, 2015, including asset quality, CE, financial structure, legal structure, and originator and servicer quality.
Fitch's analysis incorporated a review of collateral characteristics, in particular, focusing on delinquent and defaulted loans within the pool. All loans over 60 days delinquent were deemed defaulted loans. The defaulted loans were applied loss and recovery expectations based on collateral type and historical recovery performance to establish an expected net loss assumption for the transaction. Fitch stressed the cashflow generated by the underlying assets by applying its expected net loss assumption. Furthermore, Fitch applied a loss multiplier to evaluate break-even cash flow runs to determine the level of expected cumulative losses the structure can withstand at a given rating level. The loss multiplier scale utilized is consistent with Fitch's 'Criteria for Rating U.S. Equipment Lease and Loan ABS', dated Dec. 23, 2014.
Additionally, Fitch's analysis focused on concentration risks within the pool, by evaluating the impact of the default of the largest performing obligors. The obligor concentration analysis is consistent with the previously mentioned equipment criteria. The analysis compares expected loss coverage relative to the default of a certain number of the largest obligors. The required net obligor coverage varies by rating category. The required number of obligors covered ranges from 20 at 'AAA' to five at 'B'. Fitch applied loss and recovery expectations based on collateral type and historical recovery performance to the largest performing obligors commensurate with the individual rating category. The expected loss assumption was then compared to the modeled loss coverage available to the outstanding notes given Fitch's expected losses on the currently delinquent loans. Fitch also applied the 'Criteria for Rating Caps and Limitations in Global Structured Finance Transactions' dated May 28, 2014 in determining the ratings.
While the stresses loss approach was the primary driver, its results were compared to the obligor concentration approach and qualitative factors such the results of these approaches compared to prior reviews, recent performance, and available CE. The rating actions taken were ultimately the result of a combination of these factors. Fitch will continue to closely monitor these transactions and may take additional rating action in the event of changes in performance and CE measures.
RATING SENSITIVITIES
Loss severity greater than assumed for the pool and increases in delinquencies may result in downgrades of the notes. Additionally, while current obligor concentrations remain limited, they may pose risks as the transaction amortizes. However, if CE continues growing for the classes and loss severity is similar to Fitch's assumptions, the classes will likely have Stable ratings over the near term.
DUE DILIGENCE USAGE
No third party due diligence was provided or reviewed in relation to this rating action.
Additional information is available at www.fitchratings.com.
Applicable Criteria
Counterparty Criteria for Structured Finance and Covered Bonds (pub. 14 May 2014)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=744158
Criteria for Rating Caps and Limitations in Global Structured Finance Transactions (pub. 28 May 2014)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=748781
Global Structured Finance Rating Criteria (pub. 31 Mar 2015)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=864268
Additional Disclosures
Dodd-Frank Rating Information Disclosure Form
https://www.fitchratings.com/creditdesk/press_releases/content/ridf_frame.cfm?pr_id=986479
Solicitation Status
https://www.fitchratings.com/gws/en/disclosure/solicitation?pr_id=986479
Endorsement Policy
https://www.fitchratings.com/jsp/creditdesk/PolicyRegulation.faces?context=2&detail=31
ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150616006246/en/
Fitch Ratings
Surveillance Analyst
Primary Analyst
Thomas
Kaiser, CPA
Associate Director
+1-312-368-3338
Fitch
Ratings, Inc.
70 W. Madison Street
Chicago, IL 60602
or
Committee
Chairperson
Hylton Heard
Senior Director
+1-212-908-0214
or
Media
Relations:
Sandro Scenga, +1-212-908-0278
[email protected]
Source: Fitch Ratings
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investeringsforeningen ValueInvest Danmark – Indkaldelse til ekstraordinær generalforsamling
- Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™
- The Top 5 Best Book Marketing Companies to Skyrocket Sales and Reader Engagement
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Fitch RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share